Epigenomics AG reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 0.339227 million compared to EUR 0.899 million a year ago. Net loss was EUR 4.46 million compared to EUR 1,730.4 million a year ago.